微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 28.69% | -6.07% | -1.25% | 35/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 29.06% | -10.55% | 0.89% | 36/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 28.8% | -3.46% | -4.25% | 34/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 30.08% | -4.23% | -1.54% | 39/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 30.55% | 6.45% | -5.95% | 40/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 32.48% | 12.27% | 8.88% | 39/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 29.83% | 19.16% | -5.01% | 40/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 31.4% | 17.27% | 9.44% | 41/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 28.7% | 15.02% | -0.81% | 39/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 28.93% | 17.41% | 15.56% | 41/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 25.03% | 13.91% | -6.52% | 37/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 26.78% | -4.97% | 7.34% | 44/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 24.95% | -3.91% | 1.26% | 36/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 24.64% | 2.51% | 12.12% | 44/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 21.98% | 20.36% | -22.02% | 29/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 28.18% | 6.77% | 8.53% | 43/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 25.97% | -2.38% | 8.03% | 30/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 24.04% | -10.66% | 31.64% | 34/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 18.26% | -46.68% | -30.82% | 26/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 26.4% | 22.57% | -0.77% | 44/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 26.6% | -13.15% | -1.13% | 27/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 26.9% | -13.53% | -21.44% | 31/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 34.25% | -4.25% | 59.03% | 21/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 21.53% | -32.32% | -29.69% | 46/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 30.63% | -6.8% | -1.56% | 25/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 31.11% | -1.21% | -13% | 30/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 35.77% | 5.23% | 12.41% | 20/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 31.82% | -11.62% | -3.18% | 33/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 32.86% | 0.85% | 4.34% | 22/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 31.5% | -6.01% | -7.34% | 24/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 33.99% | 3.61% | -5.59% | 15/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 36% | -23.13% | 10.48% | 22/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 32.59% | -32.36% | -2.76% | 14/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 33.51% | -31.7% | 2.15% | 15/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 32.81% | -38.76% | -29.95% | 11/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 46.83% | -21.94% | -2.79% | 10/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 48.18% | -21.97% | -1.8% | 2/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 49.06% | -24.63% | -8.41% | 3/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 53.57% | -16.04% | -10.72% | 1/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |